Medicare deadline for LVADs
This article was originally published in The Gray Sheet
Executive Summary
July 14 due date is set for the Medicare Coverage Advisory Committee's final decision on coverage of left ventricular assist devices as destination therapy (1"The Gray Sheet" March 17, 2003, p. 16). 2Minutes and a transcript for the March 12 MCAC meeting are now available...
You may also be interested in...
LVAD Panel Review Raises Profile Of Medicare Cost Effectiveness Evaluation
The cost-effectiveness of new therapies should be considered by CMS during the Medicare coverage process, according to some members of the Medicare Coverage Advisory Committee
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.